FP14.11 Icotinib versus Chemotherapy as Adjuvant Treatment for Stage II–IIIA EGFR-Mutant NSCLC (EVIDENCE): A Randomized, Open-Label, Phase 3 StudyCaicun Zhou, Li Mao, Wenhua Liang et al.|Journal of Thoracic Oncology|2021Cited by 5
Effects of Degreasing Pretreatment on Immunohistochemistry and Molecular Analysis of Gastrointestinal and Breast Cancer SamplesJin Su, De Wu, Yanggeling Zhang et al.|Laboratory Investigation|2024Cited by 0